Replies to post #85379 on Intellicell Biosciences Inc (fka SVFC)

[MB25]

They have a fraction of the shares outstanding and a fraction of a fraction of the shares authorized, they are regularly communicating with shareholders, and their debt structure is different.

[gempicker]

Cytori increased in market valuation by 40 million on FDA news bringing total company valuation over 100 million.

Although they are clearly more advanced in personnel and with multiply clinicals in progress, they also have way more debt and overhead to pay for and utilizing a technology that is more cumbersome and at risk of being obsolete in the future....

Much much greater risk reward in SVFC..